Minor nondisabling acute ischemic stroke
Educational use only. Not clinically reviewed62-year-old woman for calm minor-stroke function review, qualified strategy intent, serial surveillance, and active-risk handoff. About 8 simulated minutes.
What you will practise
- Connect the symptom clock, focal deficit, individualized function, physiology, and whole-patient state.
- Review the fixed imaging, glucose, physiology, open mimics, and immediate-threat boundary.
- Recognize the individually nondisabling minor-stroke boundary without relying on NIHSS alone.
- Record qualified antiplatelet-strategy and neurological-surveillance ownership.
- At a strict later report, compare the fixed neurological and whole-patient trajectory.
- After another elapsed interval, hand off etiology, recurrence, secondary-prevention, surveillance, and active-risk work.
Review and sources
Not clinically reviewed. No clinician has signed this scenario.
- Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026;57:e317-e473. doi:10.1161/STR.0000000000000513.
- Chen HS, Cui Y, Zhou ZH, et al. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial. JAMA. 2023;329:2135-2144. doi:10.1001/jama.2023.7827.
- Khatri P, Kleindorfer DO, Devlin T, et al. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018;320:156-166. doi:10.1001/jama.2018.8496.
Open Sim Lab is an educational simulator, not for clinical use. It is not a clinical decision-support tool, not a dosing calculator, and is not validated for any decision affecting a real patient.